News

AstraZeneca announced that it has completed the previously communicated agreement with Atnahs Pharma (Atnahs) to divest its global commercial rights to Inderal (propranolol), Tenormin…
Read More...

Mateon Therapeutics, Inc. dedicated to development OT-101, a TGF-Beta antisense drug candidate, provided an update on its rapid antiviral response program initially targeting the…
Read More...

Samsung Biologics (207940.KS) and STCube announced a strategic development and manufacturing service agreement for STT-003 antibody, an anti-cancer drug candidate. Under the…
Read More...

Gilead Sciences, Inc. and Forty Seven, Inc. announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire Forty Seven for $95.50 per share…
Read More...

Takeda Pharmaceutical Company Limited announced that it has entered into an agreement to divest a portfolio of select non-core products exclusively in Latin America to Hypera S.A.,…
Read More...

Genentech, a member of the Roche Group announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Esbriet (pirfenidone) for adults with…
Read More...

zPREDICTA is pleased to announce that it has entered into a strategic collaboration with LabCorp, a leading global life sciences company. The agreement will support the adoption of…
Read More...

Altasciences, a mid-size CRO specializing in a flexible, innovative approach to providing comprehensive early stage drug development from lead candidate selection to proof of concept,…
Read More...

Biogen Inc. and Sangamo Therapeutics, Inc. announced that they have executed a global licensing collaboration agreement to develop and commercialize ST-501 for tauopathies including…
Read More...

Takeda Pharmaceutical Company Limited announced that it has acquired PvP Biologics, Inc. following the conclusion of a Phase 1 proof-of-mechanism study of investigational medicine…
Read More...

Takeda Pharmaceutical Company Limited announced that it has acquired PvP Biologics, Inc. following the conclusion of a Phase 1 proof-of-mechanism study of investigational medicine…
Read More...

Tonix Pharmaceuticals Holding Corp. announced a strategic collaboration with Southern Research to support the development of a vaccine, TNX-1800 (live modified horsepox virus vaccine…
Read More...

Novavax, Inc. announced progress in its efforts to develop a novel vaccine to protect against coronavirus disease COVID-19. Novavax has produced and is currently assessing multiple…
Read More...

Sandoz is making a public commitment to ensure stable pricing for a basket of essential medicines the company markets, which may help to treat coronavirus patients, amid growing…
Read More...

Gilead Sciences announced the initiation of two Phase 3 clinical studies to evaluate the safety and efficacy of remdesivir in adults diagnosed with COVID-19 (novel coronavirus). These…
Read More...

ProBioGen AG announced that ImmunOs Therapeutics AG has signed a Manufacturing Services Agreement for their novel platform of multitasking biologics. ProBioGen will support ImmunOs in…
Read More...

Perrigo Company plc and its partner, Catalent Pharma Solutions, announced that the U.S. Food and Drug Administration (FDA) has approved Perrigo’s abbreviated new drug application for…
Read More...

Pharmaceutics International, Inc. (Pii), a pharmaceutical contract development and manufacturing organization (CDMO), announces the expansion of its aseptic filling capacity and…
Read More...

Lysogene, a pioneering Phase 3 gene therapy platform company targeting central nervous system (CNS) diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Fast…
Read More...

TwinStrand Biosciences announced the launch of TwinStrand Duplex Sequencing Technology kits at the annual Advances in Genome Biology and Technology (AGBT) General Meeting in Marco…
Read More...